Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.45 |
| ▸ | PPARG | P37231 | 7/20 | 0.45 |
| ▸ | PPARD | Q03181 | 7/20 | 0.45 |
| ▸ | PPARA | Q07869 | 7/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.45 |
| ▸ | TSHR | P16473 | 4/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | TLR2 | O60603 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | FABP4 | P15090 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.45 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | PDE4A | P27815 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7500721 | 1.00 | PLA2G2A (0.46) | PLA2G2AGPR84PPARGPPARDPPARA | |
| SCHEMBL7497643 | 1.00 | PLA2G2A (0.46) | PLA2G2AGPR84PPARGPPARDPPARA | |
| SCHEMBL3850624 | 1.00 | PLA2G2A (0.46) | PLA2G2AGPR84PPARGPPARDPPARA | |
| SCHEMBL5495142 | 1.00 | PLA2G2A (0.46) | PLA2G2AGPR84PPARGPPARDPPARA | |
| Water SCHEMBL6811805 | 0.98 | PLA2G2A (0.44) | PLA2G2AGPR84PPARGPPARDPPARA | |
| Water SCHEMBL6817168 | 0.98 | PLA2G2A (0.44) | PLA2G2AGPR84PPARGPPARDPPARA | |
| Water SCHEMBL6813179 | 0.98 | PLA2G2A (0.44) | PLA2G2AGPR84PPARGPPARDPPARA | |
| Water SCHEMBL20401198 | 0.90 | PPARG (0.54) | PPARGPPARDPPARATSHRPTPN1 | |
| Glycinebetaine SCHEMBL1804705 | 0.84 | PLA2G2A (0.39) | PLA2G2AFABP3 | |
| SCHEMBL27879716 | 0.82 | PLA2G2A (0.44) | PLA2G2AGPR84PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117045862-A | Degradable artificial valve material | 南京圣德医疗科技有限公司 | 2023-11-14 | — | — | CN | claimed |
| CN-117561321-A | Composition and method for producing the same | 联合利华知识产权控股有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-117177913-A | Composition and method for producing the same | 联合利华知识产权控股有限公司 | 2023-12-05 | — | — | CN | disclosed |
| CN-102655921-B | Method and composition for removing impurities from impurity-loaded organic salts | CYTEC TECH CORP | 2015-05-20 | — | — | CN | disclosed |
| US-20140017301-A1 | DRUG-FREE COMPOSITIONS AND METHODS FOR DIMINISHING PERIPHERAL INFLAMMATION AND PAIN | CEVC GREGOR (DE) | 2014-01-16 | — | — | US | disclosed |
| EP-2512614-A1 | METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES FROM AN IMPURITY-LOADED IONIC LIQUID | Cytec Technology Corp. (US) | 2012-10-24 | — | — | EP | disclosed |
| WO-2012126965-A1 | DRUG-FREE COMPOSITIONS AND METHODS FOR DIMINISHING PERIPHERAL INFLAMMATION AND PAIN | CEVC GREGOR (DE) | 2012-09-27 | — | — | WO | disclosed |
| CN-102655921-A | Method and composition for removing impurities from impurity-loaded organic salts | CYTEC TECH CORP | 2012-09-05 | — | — | CN | disclosed |
| WO-2011081764-A1 | METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES FROM AN IMPURITY-LOADED IONIC LIQUID | CYTEC TECHNOLOGY CORP. (US) | 2011-07-07 | — | — | WO | disclosed |
| EP-0789589-A1 | COMPOSITION, DEVICE, AND METHOD FOR ELECTROTRANSPORT AGENT DELIVERY | ALZA CORPORATION (US) | 1997-08-20 | — | — | EP | disclosed |
| WO-1996014869-A1 | COMPOSITION, DEVICE, AND METHOD FOR ELECTROTRANSPORT AGENT DELIVERY | ALZA CORPORATION (US) | 1996-05-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140017301-A1 | DRUG-FREE COMPOSITIONS AND METHODS FOR DIMINISHING PERIPHERAL INFLAMMATION AND PAIN | EXOSC9, EXOSC5, TNNC1 | PLA2G2A 46/4885GPR84 2570/4885PPARG 369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.